In a significant advancement in the ongoing battle against cancer,medical researchers have completed the first ever FDA-approved human clinical trial of Apatone. Demonstrating promising results, ...

Teams of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®. The drug Apatone makes use of a new ...

A team of researchers has completed the first ever clinical trial of a drug called Apatone, with promising results in end-stage prostate cancer patients. A team of researchers from Summa Health System ...

AKRON, Ohio--(BUSINESS WIRE)--Researchers from the Mayo Clinic and representatives from IC-MedTech signed a collaborative research agreement with Summa Health System to study the usage of Apatone ®, a ...

A partnership between Kent State University, Summa Health System and IC-MedTech Inc. has yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively ...

Mayo Clinic and Summa Health System are collaborating on a study on treating polycystic liver and kidney disease. The research will focus on Apatone, a drug from San Diego-based IC-MedTech that’s also ...

Scott, Mark voted for the top. Your vote? I agree. Local researchers are seeking to tap into Kent State University's vast knowledge of liquid crystal technology to fuel liquid crystal pharmaceutical ...

In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human ...

“The results of the trial are very promising. Sixteen of the 17 patients responded positively to the Apatone and 13 showed a decrease in PSA velocity and an increase in PSA doubling time. At the end ...